Introduction: A terminal myelocystocele, a closed form of a neural tube def
ect (NTD), can present as a large, fully epithelialized, cystic lumbosacral
mass containing fat, cerebrospinal fluid (CSF) and neural tissue. The spin
al cord terminates at a neural placode wherein the central canal opens into
a CSF-filled cavity that is distinct from fluid in the subarachnoid space
surrounding the spinal cord. This form of NTD, in our experience, was only
associated with major caudal cell mass abnormalities, as these patients oft
en have maldevelopment of the lower spine, pelvis, genitalia, bowel, bladde
r, kidney and the abdominal wall. This study will describe the clinical man
ifestations, surgical management and long-term outcome of our terminal myel
ocystocele patients. Methods: To characterize this rare entity, a 13-year r
etrospective review was undertaken at our institution. Results: Nine patien
ts with terminal myelocystoceles were identified. In all cases, there were
multiple congenital defects including cloacal exstrophy, imperforate anus,
omphalocele, pelvic deformity, equinovarus or renal abnormality. Only 1 out
of 9 patients has required a shunt for hydrocephalus. The main goal of neu
rosurgical intervention was to reduce the size of the mass, which can slowl
y enlarge over time. The spinal cord was also untethered, although these pa
tients have no chance of bowel or bladder control. With a mean follow-up of
63 months, all patients remained neurologically stable. Impairment of lowe
r extremity function is usually severe. However, some patients were ambulat
ory with the aid of a walker or orthotic device. All patients required a pr
olonged hospital stay as well as multiple operations prior to initial disch
arge. Conclusion: Experienced, multispecialty care is needed to optimize th
e long-term outcome of these complex patients. Copyright (C) 2000 S. Karger
AG, Basel.